Sara M. Carian

SARA CARIAN focuses on all aspects of mergers and acquisitions, including stock and asset acquisitions and divestitures, complex carve-out transactions, cross-border transactions and joint ventures. Sara represents strategic and private equity buyers and sellers and public and private companies.

Notable transactions include representing the following:

• The Nemetschek Group in its acquisition of Firmus AI through its subsidiary Bluebeam, Inc.
• Salesforce in its acquisition of Vlocity, Inc. for US$1.33 billion and its acquisition of CloudCraze.
• Armis, a leading asset intelligence cybersecurity company, in its acquisition of Silk Security.
• Quest in its acquisitions of Binary Tree, a leading provider of cloud migration and modernization solutions for Microsoft Platforms, Quadrotech, a leading provider of Microsoft 365 and Office 365 migration and management, and erwin, Inc., a provider of data modeling, metadata management and data intelligence and business process modeling products.
• WatchGuard Technologies, a global leader in network security and intelligence, advanced endpoint protection, multi-factor authentication and secure Wi-Fi, in its sale to Vector Capital.
• CloudSense in its sale to Skyvera.
• Stackbit Inc., a developer of a website-designing technology platform, in its sale to Netlify.
• Autodesk, Inc. in its acquisition of Upchain Inc.
• Zingbox, Inc. in its sale to Palo Alto Networks.
• Centrify Corporation in connection with a majority investment by an affiliate of Thoma Bravo.
• Cadence Design Systems, Inc. in its acquisitions of nusemi inc and SFM Technology, Inc.
• Brocade Communication Systems, Inc. in its sales of certain software assets.
• McAfee in its acquisition of Light Point Security.
• Vector Capital in its sale of Corel Corporation to KKR.
• Corel Corporation in its acquisition of the Parallels business.
• DaVita, Inc. in the formation of Mozarc Medical, its joint venture with Medtronic, a kidney care-focused medical device company focused on developing broad suite of novel kidney care products and solutions.
• Roche in its acquisition of diagnostics company GenMark (NSDQ:GNMK) for US$1.8 billion.
• Gamma Biosciences, a life sciences tools platform created by KKR, in its acquisitions of Nanopareil, a developer of nanofiber membrane products for chromatographic separation in bioproduction, and Essential Life Solutions, a provider of chromatography columns and accessories used in life science research and bioprocess development.
• Acerus Pharmaceuticals in its acquisition of Serenity Pharmaceuticals, a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders, and the global rights to its Noctiva brand.
• Varian Medical Systems in its acquisitions of Endocare, Alicon, and Boston Scientific’s microsphere and bland embolic bead business.
• Volkswagen AG in its co-investment with Ford Motor Company in autonomous vehicle technology company, Argo AI, valuing Argo at US$7.1 billion.
• Resident Home, Inc. in its sale to Ashley Home, Inc., an affiliate of Ashley Global Retail, LLC.
• Henkels & McCoy Group Inc., a large U.S. private electrical power transmission and distribution utility services firm, in its sale to MasTec, Inc. for US$600 million.
• Variant Equity in its acquisition of Coach USA Administration, Inc. from Stagecoach Group Plc.
• Centerview Partners LLP as financial advisor to the Independent Transaction Committee of the Board of Directors of Sprint Corporation in connection with the proposed combination of Sprint and T-Mobile US, Inc. valued at US$146 billion.